Yin Huajie from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences introduces an innovative way to improve esterification reactions, which are key processes in industries ...

Many people still believe the benefits of taking an aspirin every day to prevent heart attacks and strokes outweigh the potential dangers – despite experts warning of the contrary more than five ...

If you're over the age of 60, you've likely seen headlines in the last couple of years warning against previous medical advice to take aspirin as a preventative measure against heart attack and ...

The debate over whether people ages 60 and up should take aspirin continues as medical experts learn more about the potential pros and cons of long-term use. Aspirin is an over-the-counter ...

A recent survey reveals nearly half of U.S. adults misunderstand the current guidelines on daily low-dose aspirin. The updated recommendations discourage its use for primary prevention of heart ...

If you have ever had a heart attack, a healthcare provider has probably told you to carry an aspirin or two with you at all times to have available if you ever think you might be having another heart ...

A new survey found that 1 in 5 adults “who say they have no personal or family history of heart attack or stroke,” reported “routinely” taking a low-dose aspirin Kimberlee Speakman is a ...

Aspirin is not only one of the best-documented medicines in the world, but also one of the most frequently used drugs of all times. In addition to its role as an analgesic, aspirin is being ...

School of Chemistry, Chemical Engineering and Life Science, Hubei Key Laboratory of Nanomedicine for Neurodegenerative Diseases, Wuhan University of Technology, Wuhan 430070, China ...

Nearly half of U.S. adults still believe that the benefits of taking low-dose aspirin daily outweighs the risks — despite new guidance that suggests otherwise, according to a new survey.

A clinical trial involving 1,587 participants across 11 countries found that aspirin, taken for three years following standard adjuvant therapy for high-risk Dukes' B and C colorectal cancer, did ...